| A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer (NCT03086369) | Eli Lilly and Company | 2017-06-22 |
| Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer (NCT03430479) | Kyoto Breast Cancer Research Network | 2017-06-22 |
| Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma (NCT03108495) | Iovance Biotherapeutics, Inc. | 2017-06-22 |
| Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (NCT03191864) | Adare Pharmaceuticals, Inc. | 2017-06-22 |
| Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC (NCT03428295) | Dose Safety Inc. | 2017-06-22 |
| AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03127514) | Amylyx Pharmaceuticals Inc. | 2017-06-22 |
| Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B (NCT03307980) | Pfizer | 2017-06-22 |
| Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) (NCT03068754) | Mallinckrodt | 2017-06-22 |
| Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation (NCT03121534) | M.D. Anderson Cancer Center | 2017-06-22 |
| Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer (NCT03207139) | Chang Gung Memorial Hospital | 2017-06-22 |
| Anti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast Cancer (NCT03430466) | Kyoto Breast Cancer Research Network | 2017-06-22 |
| A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT03181633) | Alexion Pharmaceuticals, Inc. | 2017-06-22 |
| Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066 (NCT03198767) | Novartis Pharmaceuticals | 2017-06-21 |
| Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia (NCT03176771) | Tanabe Pharma Corporation | 2017-06-21 |
| Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies (NCT03056339) | M.D. Anderson Cancer Center | 2017-06-21 |
| A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma (NCT02994251) | Yale University | 2017-06-21 |
| Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation (NCT03224299) | Becton, Dickinson and Company | 2017-06-21 |
| The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (NCT03178669) | InDex Pharmaceuticals | 2017-06-21 |
| Using Biomarkers to Predict TB Treatment Duration (NCT02821832) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-21 |
| VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease (NCT02898753) | Valerion Therapeutics, LLC | 2017-06-21 |
| Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth (NCT03229759) | Becton, Dickinson and Company | 2017-06-21 |
| A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A (NCT03061201) | Pfizer | 2017-06-21 |
| Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NCT03116529) | University of Maryland, Baltimore | 2017-06-21 |
| Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea (NCT03079531) | Anne Chang | 2017-06-21 |
| An Explorative Study of Afatinib in the Treatment of Advanced Cancer Carrying an EGFR, a HER2 or a HER3 Mutation (NCT03810872) | Universitair Ziekenhuis Brussel | 2017-06-21 |
| Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis (NCT02968810) | National Cancer Institute (NCI) | 2017-06-21 |
| Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma (NCT03147885) | Barbara Ann Karmanos Cancer Institute | 2017-06-20 |
| Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer (NCT03175016) | Tianjin Medical University Cancer Institute and Hospital | 2017-06-20 |
| Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery (NCT03148275) | National Cancer Institute (NCI) | 2017-06-20 |
| A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy (NCT03015623) | Sentien Biotechnologies, Inc. | 2017-06-20 |
| Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas (NCT03136055) | University of California, San Francisco | 2017-06-20 |
| Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism (NCT03226171) | Sanwa Kagaku Kenkyusho Co., Ltd. | 2017-06-20 |
| A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer (NCT03212469) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-06-20 |
| Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer (NCT03078751) | Novartis Pharmaceuticals | 2017-06-20 |
| Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery (NCT02949284) | Rutgers, The State University of New Jersey | 2017-06-20 |
| Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer (NCT03124433) | Singapore General Hospital | 2017-06-20 |
| Optimising Pacemaker Therapy for Contractility (NCT02964650) | University of Leeds | 2017-06-20 |
| Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study (NCT03120533) | University Hospital, Grenoble | 2017-06-20 |
| A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility (NCT03386552) | Isifer AB | 2017-06-20 |
| Induction Chemotherapy for Locally Advanced Esophageal Cancer (NCT03110926) | University of Rochester | 2017-06-19 |
| Contralaterally Controlled Functional Electrical Stimulation Plus Video Games for Hand Therapy After Stroke (NCT03058796) | VA Office of Research and Development | 2017-06-19 |
| Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia (NCT02981628) | Children's Oncology Group | 2017-06-19 |
| Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy (NCT07242365) | Jonsson Comprehensive Cancer Center | 2017-06-19 |
| Effect of Denosumab in Erosion Healing in RA (NCT03239080) | Chinese University of Hong Kong | 2017-06-19 |
| A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer (NCT03131206) | Dana-Farber Cancer Institute | 2017-06-19 |
| MIROCALS: Modifying Immune Response and OutComes in ALS (NCT03039673) | Centre Hospitalier Universitaire de Nīmes | 2017-06-19 |
| Lipoic Acid Supplement for Cystine Stone (NCT02910531) | Thomas Chi, MD | 2017-06-19 |
| Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine (NCT03284710) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-19 |
| Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy (NCT02925000) | Taiwan Liposome Company | 2017-06-19 |
| Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients (NCT03145480) | Northwell Health | 2017-06-19 |
| Faecal Bacteriotherapy for Ulcerative Colitis (NCT03104036) | Institute for Clinical and Experimental Medicine | 2017-06-19 |
| Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients (NCT03391609) | Assiut University | 2017-06-18 |
| Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer (NCT03072160) | National Cancer Institute (NCI) | 2017-06-16 |
| Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT04004221) | BeiGene | 2017-06-16 |
| Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease (NCT03157037) | Mårten Segelmark | 2017-06-16 |
| Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types (NCT03012581) | UNICANCER | 2017-06-16 |
| Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer (NCT03158129) | M.D. Anderson Cancer Center | 2017-06-16 |
| Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL (NCT03128879) | M.D. Anderson Cancer Center | 2017-06-16 |
| CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery) (NCT03167905) | KK Women's and Children's Hospital | 2017-06-15 |
| A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT03164057) | St. Jude Children's Research Hospital | 2017-06-15 |
| Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer (NCT03180437) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Liver Cancer (NCT03183219) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Treatment of Oculopharyngeal Muscular Dystrophy With Trehalose (NCT04226924) | Bioblast Pharma Ltd. | 2017-06-15 |
| EGFR CART Cells for Patients With Metastatic Colorectal Cancer (NCT03152435) | Shenzhen Second People's Hospital | 2017-06-15 |
| Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease (NCT03376698) | University of the Ryukyus | 2017-06-15 |
| Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B (NCT03109730) | Assembly Biosciences | 2017-06-15 |
| Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults (NCT03043365) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-15 |
| Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 on Gingival Mucosal Tissue in Normal Volunteers (NCT03233737) | Cetylite Industries | 2017-06-15 |
| Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation (NCT03172234) | Ghada Mohammed AboelFadl | 2017-06-15 |
| A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread (NCT03098550) | Bristol-Myers Squibb | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Breast Cancer (NCT03183206) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL) (NCT03135262) | Hoffmann-La Roche | 2017-06-15 |
| Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases (NCT03175432) | M.D. Anderson Cancer Center | 2017-06-15 |
| TRA for Preventing Symptomatic Urinary Tract Infection Among High-risk Elderly Residing in Nursing Homes (NCT04272437) | Changhua Christian Hospital | 2017-06-15 |
| Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD) (NCT02978144) | Columbia University | 2017-06-15 |
| Safety and Efficiency of γδ T Cell Against Lung Cancer (NCT03183232) | Fuda Cancer Hospital, Guangzhou | 2017-06-15 |
| Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer (NCT03007979) | Washington University School of Medicine | 2017-06-15 |
| ZS Ph2/3 Dose-response Study in Japan (NCT03127644) | AstraZeneca | 2017-06-14 |
| Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years (NCT03179423) | GeNeuro Australia PTY Ltd | 2017-06-14 |
| Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) (NCT03111732) | National Cancer Institute (NCI) | 2017-06-14 |
| Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia (NCT02882282) | M.D. Anderson Cancer Center | 2017-06-14 |
| The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis (NCT03020719) | University of Minnesota | 2017-06-14 |
| Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) (NCT03150004) | Medical College of Wisconsin | 2017-06-14 |
| Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease (NCT02648581) | Assistance Publique - Hôpitaux de Paris | 2017-06-14 |
| Dose-ranging Study of Nemolizumab in Atopic Dermatitis (NCT03100344) | Galderma R&D | 2017-06-14 |
| Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer (NCT03187314) | Hangzhou Cancer Hospital | 2017-06-14 |
| A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors (NCT02110069) | Boston Children's Hospital | 2017-06-14 |
| Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer (NCT02846792) | University of Washington | 2017-06-14 |
| Gene Therapy for Haemophilia A. (NCT03001830) | University College, London | 2017-06-14 |
| PD-1 Inhibition in Advanced Myeloproliferative Neoplasms (NCT03065400) | John Mascarenhas | 2017-06-14 |
| Midazolam in Supraclavicular Brachial Plexus Block (NCT03185351) | Assiut University | 2017-06-14 |
| Study of Pomalidomide in Anal Cancer Precursors (NCT03113942) | Kirby Institute | 2017-06-14 |
| Study in Subjects With Light Chain (AL) Amyloidosis (NCT03154047) | Prothena Biosciences Ltd. | 2017-06-14 |
| An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer (NCT03077698) | Xenetic Biosciences, Inc. | 2017-06-14 |
| the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment (NCT03358004) | Mario Negri Institute for Pharmacological Research | 2017-06-14 |
| Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer? (NCT02945566) | University of Birmingham | 2017-06-14 |
| Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM (NCT03213002) | Northwell Health | 2017-06-13 |
| Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement (NCT02952573) | University Health Network, Toronto | 2017-06-13 |
| Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome (NCT03173937) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-13 |
| Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma (NCT02899195) | PrECOG, LLC. | 2017-06-13 |